An immunomodulatory drug called fingolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune cells, according to a study published ...
12 hours ago
0
5
Men at particular risk for HIV are very likely to consistently take prevention medication during vacations when their odds of contracting the virus are higher, according to a new study led by scientists at the University ...
Aug 12, 2020
0
2
Over the past year, there has been an influx of ads on social media seeking plaintiffs in lawsuits for harms and side-effects caused by the pre-exposure prophylaxis (PrEP) drug tenofovir disoproxil fumarate/Emtricitabine ...
Aug 12, 2020
0
2
After looking at the health records of over 10,000 patients with both HIV and multidrug resistant tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania ...
Aug 10, 2020
0
2
When her regular clinic ran out of her government-funded HIV medications amid South Africa's COVID-19 lockdown, Sibongile Zulu panicked. A local pharmacy had the drugs for $48, but she didn't have the money after being laid ...
Aug 11, 2020
0
3
